AstraZeneca PLC (AZN)
178.84
-4.59
(-2.50%)
USD |
NYSE |
Jun 10, 16:00
179.00
+0.16
(+0.09%)
After-Hours: 20:00
AstraZeneca EPS Diluted (TTM) : 3.330 for March 31, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| March 31, 2026 | 3.330 |
| December 31, 2025 | 3.279 |
| September 30, 2025 | 3.012 |
| June 30, 2025 | 2.663 |
| March 31, 2025 | 2.485 |
| December 31, 2024 | 2.249 |
| September 30, 2024 | 2.081 |
| June 30, 2024 | 2.064 |
| March 31, 2024 | 2.029 |
| December 31, 2023 | 1.908 |
| September 30, 2023 | 1.891 |
| June 30, 2023 | 1.977 |
| March 31, 2023 | 1.509 |
| December 31, 2022 | 1.055 |
| September 30, 2022 | 0.6528 |
| June 30, 2022 | -0.4253 |
| March 31, 2022 | -0.3321 |
| December 31, 2021 | 0.136 |
| September 30, 2021 | 0.6336 |
| June 30, 2021 | 1.432 |
| March 31, 2021 | 1.512 |
| December 31, 2020 | 1.217 |
| September 30, 2020 | 0.951 |
| June 30, 2020 | 0.8181 |
| March 31, 2020 | 0.5797 |
| Date | Value |
|---|---|
| December 31, 2019 | 0.5165 |
| September 30, 2019 | 0.8052 |
| June 30, 2019 | 0.8614 |
| March 31, 2019 | 0.95 |
| December 31, 2018 | 0.8513 |
| September 30, 2018 | 0.9583 |
| June 30, 2018 | 1.058 |
| March 31, 2018 | 1.110 |
| December 31, 2017 | 1.185 |
| September 30, 2017 | 1.395 |
| June 30, 2017 | 1.525 |
| March 31, 2017 | 1.334 |
| December 31, 2016 | 1.376 |
| September 30, 2016 | 0.9705 |
| June 30, 2016 | 0.875 |
| March 31, 2016 | 1.151 |
| December 31, 2015 | 1.116 |
| September 30, 2015 | 0.6723 |
| June 30, 2015 | 0.4673 |
| March 31, 2015 | 0.5089 |
| December 31, 2014 | 0.4924 |
| September 30, 2014 | 0.4004 |
| June 30, 2014 | 0.7912 |
| March 31, 2014 | 0.7976 |
| December 31, 2013 | 0.9938 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| GSK Plc | 3.824 |
| Johnson & Johnson | 8.649 |
| Eli Lilly & Co. | 27.78 |
| Merck & Co., Inc. | 3.553 |
| Novo Nordisk A/S | 4.261 |